Stephen E. Hubbs

Asymmetric Synthesis of the Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib

David B. Damon, Robert W. Dugger, Stephen E. Hubbs et al. · Organic Process Research & Development · 2006 · 62 citations

Combinatorial Chemistry, Medicinal Chemistry, Biosynthesis +15

Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors

Jian Lin, Wei Lu, Justin A. Caravella et al. · Journal of Medicinal Chemistry · 2019 · 46 citations · Full text

Commercialization and Late-Stage Development of a Semisynthetic Antifungal API: Anidulafungin/<scp>d</scp>-Fructose (Eraxis)

Timothy Norris, John VanAlsten, Stephen E. Hubbs et al. · Organic Process Research & Development · 2008 · 26 citations

Bioorganic Chemistry, Fungal Cell Biology, Medicinal Fungi +17

Design and Optimization of Benzopiperazines as Potent Inhibitors of BET Bromodomains

David S. Millan, Katherine J. Kayser-Bricker, Matthew W. Martin et al. · ACS Medicinal Chemistry Letters · 2017 · 18 citations · Full text

Discovery and optimization of novel piperazines as potent inhibitors of fatty acid synthase (FASN)

Matthew W. Martin, David R. Lancia, Hongbin Li et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 18 citations · Full text

Combinatorial Chemistry, Lipid Synthesis, Biochemistry +6